Chengdu Jinkai Biology Engineering Co., Ltd.announced that it will receive CNY 37,150,000 in equity funding from existing investor Shenzhen Salubris Pharmaceuticals Co., Ltd. on December 3, 2015. Pursuant to the transaction, the investor's stake will increase from 80% to 90%. The company's registered capital would increase from CNY 37,150,000 to CNY 74,300,000. The transaction has been approved at 12th meeting of the 3rd directorate meeting of the investor and does not require the investor's shareholders approval.

The company reported total assets of CNY 12,201,800, total liabilities of CNY 3,500,000, net assets of CNY 8,701,200, revenue of CNY 0, and net profit of CNY -9,077,100 for the year ended December 31, 2014.